PT - JOURNAL ARTICLE AU - Alexander Sokolov AU - Lyubov Sokolova TI - Monitoring and forecasting the COVID-19 epidemic in Moscow: model selection by balanced identification technology - version: September 2021 AID - 10.1101/2021.10.07.21264713 DP - 2021 Jan 01 TA - medRxiv PG - 2021.10.07.21264713 4099 - http://medrxiv.org/content/early/2021/10/11/2021.10.07.21264713.short 4100 - http://medrxiv.org/content/early/2021/10/11/2021.10.07.21264713.full AB - A mathematical model is a reflection of knowledge on the real object studied. The paper shows how the accumulation of data (statistical data and knowledge) about the COVID-19 pandemic lead to gradual refinement of mathematical models, to the expansion of the scope of their use. The resulting model satisfactorily describes the dynamics of COVID-19 in Moscow from 19.03.2020 to 01.09.2021 and can be used for forecasting with a horizon of several months. The dynamics of the model is mainly determined by herd immunity. Monitoring the situation in Moscow has not yet (as of 01.09.2021) revealed noticeable seasonality of the disease nor an increase in infectivity (due to the Delta strain). The results of using balanced identification technology to monitor the COVID-19 pandemic are:models corresponding to the data available at different points in time (from March 2020 to August 2021);new knowledge (dependencies) acquired;forecasts for the third and fourth waves in Moscow.Discrepancies that manifested after 01.09.2021 and possible further modifications of the model are discussedCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis research was financially supported by the Russian Science Foundation (grant No. 16-11-10352)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are official statistics. References are given in the text.